Quantifying ABCA3 Protein Levels Insights from ELISA Assays


Are diagnostic tools used to quantify the concentration of ABCA3 protein in biological samples. These kits employ the Enzyme-Linked Immunosorbent Assay (ELISA) technique, utilizing specific antibodies to capture and detect ABCA3 protein molecules. By measuring the optical density or luminescence produced, these kits provide a quantitative assessment of ABCA3 levels, aiding research into lipid transport, lung surfactant production, and respiratory diseases.


 ABCA3 ELISA kits Applications 

Research in Pulmonary Biology

ABCA3 plays a critical role in lung surfactant production and lipid homeostasis in pulmonary tissues.

Drug Development and Screening

ABCA3 is implicated in multidrug resistance in cancer cells, as it mediates the efflux of chemotherapeutic agents.

Identification of Biomarkers

ABCA3 expression levels may serve as biomarkers for various diseases and conditions, including lung disorders, cancer, and metabolic syndromes.

Clinical Diagnostics

ABCA3 ELISA kits have potential clinical utility in diagnosing and monitoring pulmonary diseases and other conditions associated with dysregulated ABCA3 expression.

 ABCA3 ELISA kits Features

High Sensitivity

ABCA3 ELISA kits are designed to detect low levels of ABCA3 protein accurately, enabling researchers to quantify subtle changes in protein expression levels with high sensitivity.

Ease of Use

These kits are user-friendly and come with detailed protocols and instructions, making them suitable for researchers with varying levels of expertise in ELISA techniques.


ABCA3 ELISA kits are compatible with various sample types, including cell lysates, tissue homogenates, serum, plasma, and other biological fluids, allowing for flexibility in experimental design and sample selection  

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.
Exploring The Advancements in Monkey Total IgG ELISA Kits Type 1 Diabetes & Treatment Achieves Insulin Independence Without Immunosuppression